Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 08, 2024 18:32 ET | Source: Portnoy Law

Brooge Energy Limited f/k/a Brooge Holdings Limited f/k/a Twelve Seas investors: Please contact the Portnoy Law Firm to recover your losses; April 5, 2024 deadline

LOS ANGELES, April 08, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Brooge Energy Limited f/k/a Brooge Holdings Limited f/k/a Twelve Seas Investment Company (NASDAQ: BROG). investors that a...
April 08, 2024 18:24 ET | Source: Portnoy Law

Amylyx Pharmaceuticals, Inc. investors: Please contact the Portnoy Law Firm to recover your losses; April 9, 2024 deadline

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, April 08, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Amylyx Pharmaceuticals, Inc....
March 28, 2024 14:15 ET | Source: Portnoy Law

Amylyx Pharmaceuticals, Inc. investors: Please contact the Portnoy Law Firm to recover your losses; April 9, 2024 deadline.

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, March 28, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Amylyx Pharmaceuticals, Inc....
March 21, 2024 18:06 ET | Source: Robbins LLP

AMLX Class Action Alert: Robbins LLP Reminds Investors of Pending Lead Plaintiff Deadline – April 9, 2024 – in Amylyx Pharmaceuticals, Inc. Class Action

Robbins LLP is investigating the allegations that Amylyx Pharmaceuticals, Inc. (AMLX) misled investors regarding RELYVRIO's commercial prospects.
March 12, 2024 20:41 ET | Source: Portnoy Law

Amylyx Pharmaceuticals, Inc. investors: Please contact the Portnoy Law Firm to recover your losses; April 9, 2024 deadline

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, March 12, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Amylyx Pharmaceuticals, Inc....
March 05, 2024 16:16 ET | Source: Robbins LLP

AMLX STOCK NEWS: Lead Plaintiff Deadline is Approaching in Class Action Against Amylyx Pharmaceuticals, Inc.; Contact Robbins LLP for Information

Robbins LLP is Investigating the Allegations that Amylyx Pharmaceuticals, Inc. (AMLX) Misled Investors Regarding the Viability of its Drug for Treating ALS
February 20, 2024 15:18 ET | Source: Robbins LLP

AMLX Class Action Alert: Robbins LLP Reminds Shareholders of Lead Plaintiff Deadline in the Class Action Against Amylyx Pharmaceuticals, Inc.

Robbins LLP is Investigating the Allegations Against Amylyx Pharmaceuticals Inc.
February 12, 2024 22:28 ET | Source: Robbins LLP

Investor Notice: Robbins LLP Informs Investors of Class Action Filed Against Amylyx Pharmaceuticals, Inc. (AMLX)

Robbins LLP is Investigating the Allegations Against Amylyx Pharmaceuticals, Inc.